AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
AstraZeneca(AZN) stock is priced at $179.48, giving the company a market capitalization of 275.88B. It carries a P/E multiple of 26.67 and pays a dividend yield of 1.76%.
On 2026-06-18, AstraZeneca(AZN) stock traded between a low of $177.65 and a high of $180.44. Shares are currently priced at $179.48, which is +1.0% above the low and -0.5% below the high.
AstraZeneca(AZN) shares are trading with a volume of 1.87M, against a daily average of 1.97M.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $137.23.
In the last year, AstraZeneca(AZN) shares hit a 52-week high of $212.71 and a 52-week low of $137.23.
AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium fo...
...
Alexion, AstraZeneca (AZN) Rare Disease’s supplemental Biologics License Application, sBLA, for Ultomiris has been accepted and granted Priority Review by the U...
Analyst ratings
83%
of 29 ratingsMore AZN News
(RTTNews) - AstraZeneca's (AZN,AZN.L,ZEG.DE,AZN.ST) Truqap (capivasertib), in combination with abiraterone and prednisone, has been approved in the US as the fi...
AstraZeneca (AZN) on Friday announced that the U.S. Food and Drug Administration approved a label expansion for its anti-tumor agent Truqap (capivasertib) as pa...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is preparing a new early-stage trial that looks at how its drug AZD13...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The GRANITE study, formally titled “Airsupra Effectiveness in the Real World,” reviews...
Astrazeneca (AZN) ended the recent trading session at $75.57, demonstrating a +1.79% swing from the preceding day's closing price. This change outpaced the S&P...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.